SCS
BOLD

Syquant Capital SAS’s Audentes Therapeutics, Inc BOLD Stock Holding History

Syquant Capital SAS’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-767,502
Closed -$45.9M – 24
2019
Q4 		$45.9M Buy
+767,502
New +$28.8M 23.65% 1

Syquant Capital SAS's BOLD Position: Q1 2020 in Review

Syquant Capital SAS sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 767,502 shares — an estimated $45.9M sold.

Syquant Capital SAS first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $45.9M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Syquant Capital SAS reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Syquant Capital SAS sold 767,502 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $45.9M.
  • Syquant Capital SAS first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Syquant Capital SAS's Audentes Therapeutics, Inc position peaked at $45.9M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Syquant Capital SAS's 13F filing for Q1 2020, filed 14 Apr 2020.